Debulking metastases of pancreatic neuroendocrine tumors may be effective at a threshold of greater than or equal to 70%, indicating that liver debulking criteria could possibly be extended to this threshold. READ MORE
In concert with the peptide iRGD, nanoparticles with hollow silica cores can enhance the delivery of irinotecan to a murine model of pancreatic ductal adenocarcinoma.
ASCO has updated their recommendations for adjuvant treatment of surgically resected pancreatic cancer.
Survey: Many Clinicians Use Extended Radical Tumor Resection for Pancreatic Cancer, Despite Guidelines
The combination of gemcitabine and capecitabine offers the best survival as adjuvant therapy for patients with resected pancreatic cancer.
Research in Review
Adding radiation to chemotherapy regimens may not improve overall survival in patients with locally advanced pancreatic cancer.
Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom.